REN and type 2 diabetes mellitus: Plasma renin activity and aldosterone levels are useful markers to monitor systemic activities of the renin–angiotensin–aldosterone system.32 Further studies are needed to examine the effects of long treatment with an SGLT2 inhibitor on plasma renin activity and aldosterone levels in patients with type 2 diabetes.